0001493152-20-003043.txt : 20200226 0001493152-20-003043.hdr.sgml : 20200226 20200226203216 ACCESSION NUMBER: 0001493152-20-003043 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200221 FILED AS OF DATE: 20200226 DATE AS OF CHANGE: 20200226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stein Robert Benjamin CENTRAL INDEX KEY: 0001597158 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51353 FILM NUMBER: 20658031 MAIL ADDRESS: STREET 1: C/O AGENUS INC. STREET 2: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Protagenic Therapeutics, Inc.\new CENTRAL INDEX KEY: 0001022899 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 061390025 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 149 FIFTH AVENUE STREET 2: SUITE 500 CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: (212) 994-8200 MAIL ADDRESS: STREET 1: 149 FIFTH AVENUE STREET 2: SUITE 500 CITY: NEW YORK STATE: NY ZIP: 10010 FORMER COMPANY: FORMER CONFORMED NAME: Atrinsic, Inc. DATE OF NAME CHANGE: 20090630 FORMER COMPANY: FORMER CONFORMED NAME: NEW MOTION, INC. DATE OF NAME CHANGE: 20070504 FORMER COMPANY: FORMER CONFORMED NAME: MPLC, Inc. DATE OF NAME CHANGE: 20050608 4 1 ownership.xml X0306 4 2020-02-21 0 0001022899 Protagenic Therapeutics, Inc.\new PTIX 0001597158 Stein Robert Benjamin 149 FIFTH AVE, SUITE 500 NEW YORK NY 10010 1 0 0 0 PTIX Common stock Options 1.75 2020-02-21 4 A 0 150000 A 2021-02-21 2030-02-21 PTIX Common Stock, Par Value $0.0001 150000 150000 D As this was an option grant, there was no cost to the recipient. The options vest monthly over 12 months, beginning upon the date of grant. /s/ Robert Stein 2020-02-26